Lilly Releases Update on Corporate Responsibility Efforts

Company communicates progress on numerous indicators of economic, 
environmental and social performance 
INDIANAPOLIS, Dec. 3, 2012  /CNW/ - Eli Lilly and Company (NYSE: LLY) has 
released its 2011/2012 Corporate Responsibility Update 
( This report highlights 
progress and initiatives since Lilly's 2010/2011 full Corporate Responsibility 
Report. The update, as well as last year's full report, is available on 
Lilly's website at 
"Increasingly, we are integrating the concept of 'shared value' into the way 
we operate," said John C. Lechleiter, Ph.D., Lilly chairman, president and 
chief executive officer. "Using our business expertise to help address 
pressing social needs opens up new opportunities for us to provide solutions 
to health challenges the world over. We believe this approach will help to 
create enduring value for society and for Lilly. By making individual patients 
better, we help those patients—as well as their communities and broader 
societies—to thrive." 
Lilly, a leader in advocating for greater transparency by the 
biopharmaceutical industry, provides a comprehensive report of the company's 
progress on numerous corporate responsibility goals and efforts. The report 
includes updates on longstanding programs, as well as data for 2011. 
Included in the report are highlights indicating that Lilly: 

    --  gave more than $590 million in charitable contributions in 2011
        (including cash, products, and other in-kind donations),
        including through the company's patient assistance programs,
        which helped more than 250,000 people;
    --  unveiled The Lilly Global Health Innovation Campaign, which
        encompassses two of Lilly's signature corporate responsibility
        programs – The Lilly NCD Partnership and The Lilly MDR-TB
        Partnership – aimed at improving health for people in
        need in developing countires;
    --  received a perfect score of 100 on the Human Rights Campaign's
        "Best Places to Work: Corporate Equality Index" in 2011;
    --  selected 200 employees to volunteer two weeks each, on company
        time, in countries where people lack resources or access to
        quality health care;
    --  reduced serious injury and lost-time injury rates each by 50
        percent (from 2007 baseline);
    --  decreased water intake by more than 25 percent and waste to
        landfill by 40 percent compared to 2007;
    --  improved energy efficiency by more than 15 percent, compared to
        2007, and reduced corresponding greenhouse gas emissions by
        more than 15 percent.

The Lilly 2011/12 Corporate Responsibility Update also serves as the company's 
annual Communication on Progress to the United Nations Global Compact (UNGC). 
As a signatory of the UNGC, Lilly shares its progress annually on 10 
principles universally accepted related to human rights, labor, the 
environment and anti-corruption.

The report details the company's progress in areas such as:
    --  conducting business ethically and transparently, including the
        safe, uninterrupted supply of medicines, ethical product
        promotion, patient privacy, public disclosure of clinical trial
        results and financial payments to health care professionals;
    --  enhancing access to medicines and efforts to improve health for
        people in need, including through patient assistance programs
        and product donations;
    --  developing innovative medicines and maintaining the highest
        standards in research and development, including the use and
        care of animals in research, bioethics, patient safety and
        education, and diversity in clinical trials;
    --  supporting strong workplace practices that encompass diversity
        and inclusion; employee health, safety and wellness;
        recruiting, hiring and development; and efforts to help
        employees maintain work-life balance;
    --  engaging with patients and communities to achieve better health
        outcomes, including community-based programs that support
        patients, improving health disparities, and employee
        volunteering and giving programs;
    --  fostering environmental sustainability and reducing the
        company's environmental footprint through initiatives related
        to energy efficiency, greenhouse gases emissions, water intake
        and waste to landfill.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation is developing a growing 
portfolio of pharmaceutical products by applying the latest research from its 
own worldwide laboratories and from collaborations with eminent scientific 
organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – 
through medicines and information – for some of the world's most urgent 
medical needs. Additional information about Lilly is available at CR-LLY

(Logo: )

David Marbaugh - office, +1-317-277-5620, mobile, +1-317-489-7109

SOURCE: Eli Lilly and Company

To view this news release in HTML formatting, please use the following URL:

CO: Eli Lilly and Company
ST: Indiana

-0- Dec/03/2012 12:01 GMT

Press spacebar to pause and continue. Press esc to stop.